omniture
YUYU PHARMA

Latest News

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed ...

2025-12-02 22:00 752

Yuyu Pharma to attend 'CPHI Worldwide 2023'

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide inBa...

2023-10-18 15:00 3251

Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023

SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will participate in the Vitafood...

2023-09-21 14:06 3149

Yuyu Pharma, Dry Eye Pipeline Mechanism of Action and Pre-clinical Results Published

SEOUL, South Korea, April 27, 2023 /PRNewswire/ -- At ARVO 2023, Yuyu Pharma unveiled the results o...

2023-04-27 21:00 2654

Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment

SEOUL, South Korea, Nov. 29, 2022 /PRNewswire/ -- At the World Congress for Hair Research 2022 (Mel...

2022-11-29 16:20 3433

Yuyu Pharma attendance at European Pharmaceutical Conference

SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ -- Robert Yu, CEO of Yuyu Pharma, has been attending ...

2022-11-03 21:00 2773

Yuyu Pharma Receives ISO 37001 Anti-Bribery Management System Certification

SEOUL, South Korea, Sept. 9, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220) received the ISO 37001 ...

2021-09-09 21:00 2509

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®

SEOUL, South Korea, Aug. 3, 2021 /PRNewswire/ -- Yuyu Pharma, a pharmaceutical company based in Kor...

2021-08-03 21:00 2384

Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive.

SEOUL, South Korea, May 28, 2021 /PRNewswire/ -- Dr. Seungpil Yu is a living witness to the long hi...

2021-05-28 21:00 3593

Yuyu Pharma Publishes History for 80th Anniversary

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220, CEO Robert Wonsang Yu),...

2021-03-03 22:00 2387

Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma

SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) ...

2021-01-11 22:00 4789

Yuyu Pharma was recognized as "Family-Friendly Company" by the Ministry of Gender Equality and Family

SEOUL, South Korea, Dec. 30, 2020 /PRNewswire/ -- Yuyu Pharma(CEO Robert Wonsang Yu, KRX: 000220) r...

2020-12-30 22:00 3525